CLIA-certified

Dateline — SALT LAKE CITY, November 11, 2025:Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostic testing...

Dateline — CARLSBAD, Calif., November 11, 2025:Exagen Inc. (Nasdaq: XGN), a leader in autoimmune diagnostics, has announced its participation...